Claim
quantitative
Analysis v3

If the price of semaglutide is cut in half, it might become a good value for treating people with heart disease who are overweight or obese—even if they don’t have diabetes—because it could add...

Evidence from Studies

Supporting (1)

0

Community contributions welcome

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict